Clinical Trial Update: A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating YL201 in combination with Ivonescimab (AK112) for advanced solid tumors, including non-small cell lung cancer and small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)
• YL201

Snippet

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. | Conditions: Advanced Solid Tumors, Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING